Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

VIGABATRIN

VIGABATRIN

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview VIGABATRIN is listed in Drugs@FDA under application 215707 (ANDA).

Marketing status: Prescription Active ingredient VIGABATRIN Form and strength TABLET;ORAL - 500MG Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2026-03-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview VIGABATRIN is listed in Drugs@FDA under application 215707 (ANDA). Marketing status: Prescription Active ingredient VIGABATRIN Form and strength TABLET;ORAL - 500MG Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2026-03-18 00:00:00. Submission type: SUPPL.

Monitoring

  • Review priority: N/A
  • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.